Schedule 13G ownership disclosure

Gossamer Bio Inc

Common Stock, par value $0.0001 per share · CUSIP: 38341P102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Invus Public Equities, L.P.

    Shares: 6,258,880 · Class: 2.8%

  • Invus Public Equities Advisors, LLC

    Shares: 6,258,880 · Class: 2.8%

  • Invus Global Management, LLC

    Shares: 6,258,880 · Class: 2.8%

  • Siren, L.L.C.

    Shares: 6,258,880 · Class: 2.8%

  • Avicenna Life Sci Master Fund LP

    Shares: 0 · Class: 0%

  • Avicenna Life Sci Master GP LLC

    Shares: 0 · Class: 0%

  • Ulys, L.L.C.

    Shares: 0 · Class: 0%

  • Raymond Debbane

    Shares: 6,258,880 · Class: 2.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-018890
Form type
SCHEDULE 13G/A
Filer
Gossamer Bio, Inc.
CIK
CIK 1728117
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub